Wen-Chung Yu
Overview
Explore the profile of Wen-Chung Yu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
176
Citations
1919
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lin Y, Liu P, Tsai K, Huang W, Yu W, Sui X, et al.
Front Cardiovasc Med
. 2025 Feb;
12:1435818.
PMID: 39957997
Background: Left atrial (LA) size and function are linked to exercise intolerance in heart failure, while associations between LA parameters and exercise performance remain unclear in athletes. Objectives: This study...
2.
Hsu T, Tseng C, Kuo L, Yang C, Lin Y, Yu W, et al.
J Nucl Cardiol
. 2025 Jan;
:102147.
PMID: 39864580
Background: Amyloidosis is a multisystem disease characterized by the deposition of amyloid fibrils, leading to organ dysfunction. When cardiac amyloidosis is suspected, it is essential to screen for light chain...
3.
Chang H, Tseng C, Huang W, Lee C, Yu W, Cheng H, et al.
JACC Asia
. 2025 Jan;
4(12):928-937.
PMID: 39802988
Background: Supranormal left ventricular ejection fraction (LVEF) confers a paradoxically higher mortality risk; however, whether intrinsic structural changes of left ventricle (LV) play an important role remain unclear. Objectives: The...
4.
Chen M, Lee W, Lu C, Chang H, Tung C, Siow Y, et al.
Acta Cardiol Sin
. 2025 Jan;
41(1):1-49.
PMID: 39776929
Transthoracic echocardiography plays a crucial role in clinical diagnosis and is increasingly being used around the world. Comprehensive echocardiographic examinations require accurate measurements and the operators to have excellent technical...
5.
Wang S, Huang Y, Chen Y, Tsai C, Ko C, Lin Y, et al.
Acta Cardiol Sin
. 2025 Jan;
41(1):55-71.
PMID: 39776923
This 2025 updated consensus outlines the diagnostic strategy for transthyretin amyloid cardiomyopathy (ATTR-CM). Given that ATTR-CM is a significant contributor to heart failure, this article emphasizes the importance of making...
6.
Feng Y, Agrawal S, Yang C, Chang H, Kuo L, Yu W, et al.
Chem Asian J
. 2024 Dec;
20(4):e202401438.
PMID: 39668552
Transthyretin (TTR), a homo-tetrameric protein encoded by the TTR gene, can lead to amyloid diseases when destabilized by mutations. The TTR-Ala97Ser (A97S) mutation is the predominant pathogenic variant found in...
7.
Hung Y, Yu A, Chen Y, Tsai C, Su M, Shun C, et al.
J Formos Med Assoc
. 2024 Oct;
PMID: 39389803
Background: RNA interference therapeutics reduce transthyretin production; however, their effect on hereditary transthyretin amyloid cardiomyopathy (ATTR-CA) remains unclear. We aimed to investigate alterations in technetium-99 m (Tc)-pyrophosphate (PYP) single-photon emission...
8.
Tseng C, Huang W, Chang H, Yu W, Cheng H, Chiang C, et al.
Open Heart
. 2024 Sep;
11(2).
PMID: 39322629
Background: Heart failure (HF) with improved ejection fraction (HFimpEF) is a recently identified phenotype of HF, which had better cardiovascular outcomes compared with persistent HF with reduced ejection fraction (HFrEF)....
9.
Hung C, Wu Y, Kuo L, Sung K, Lin H, Chang W, et al.
Acta Cardiol Sin
. 2024 Sep;
40(5):544-568.
PMID: 39308653
As an X-linked inherited lysosomal storage disease that is caused by α-galactosidase A gene variants resulting in progressive accumulation of pathogenic glycosphingolipid (Gb3) accumulation in multiple tissues and organs, Fabry...
10.
Chen K, Hsu Y, Chou C, Hsu C, Chang S, Yu W, et al.
J Thromb Thrombolysis
. 2024 Aug;
57(7):1268-1280.
PMID: 39143401
It remains unclear whether non-vitamin K antagonist oral anticoagulants (NOACs) are more effective and safer than warfarin in low-weight patients with atrial fibrillation (AF). Here, we retrospectively compared the effectiveness...